Fibroids, or uterine leiomyomas, are benign tumours that grow in the uterus and affect millions of women worldwide. While these growths are typically noncancerous, they can cause a range of symptoms that greatly impact a woman's quality of life. Traditional uterine fibroids treatment included surgery, which can involve a lengthy recovery process and potential complications.
However, in recent years, a new technique called uterine artery embolization (UAE) has emerged as a promising alternative. UAE is a minimally invasive procedure that blocks fibroids' blood supply, causing them to shrink and die. The success rate of UAE, or uterine artery embolization, is estimated to be between 95-97%. In this post, we'll explore how UAE is revolutionizing fibroid treatment and why it's quickly becoming a preferred option for women seeking relief from their symptoms.
Uterine artery embolization (UAE) is a minimally invasive procedure, during the procedure, the doctor inserts a catheter into the artery that supplies blood to the uterus. The doctor then uses a special device to block the artery, which reduces or stops the blood flow to the uterus. This results in the symptoms from the uterine condition being relieved.
Once the catheter is in place, small particles are injected into the uterine arteries, which block the blood supply to the fibroids, eventually causing the fibroids to shrink and die over time. The procedure typically takes about 1-2 hours to complete and is performed under local anaesthesia.
Compared to traditional surgeries for fibroids, such as myomectomy or hysterectomy, UAE has several advantages. Here are the benefits of UAE compared to traditional surgeries for fibroids in bullet points:
Not all women are good candidates for the procedure.
Here are some symptoms of fibroids uterine and criteria for candidacy for UAE:
Uterine artery embolization (UAE) has been shown to be a highly effective treatment option for fibroids here are some statistics on the success of UAE in treating fibroids:
In terms of long-term outcomes, UAE has been shown to be comparable to traditional surgeries such as hysterectomy and myomectomy. However, UAE offers a number of advantages over these procedures, such as a shorter recovery time, preservation of fertility, and a lower risk of complications.
One potential long-term effect of UAE is that the fibroids may regrow over time. However, this is relatively rare and can be managed with additional treatments if necessary. Additionally, UAE does not increase the risk of uterine cancer or other reproductive cancers, as some traditional surgeries can.
Using Uterine Artery Embolization (UAE), fibroids can now be treated in a minimally invasive manner. With its numerous advantages, such as a shorter recovery time, fertility preservation, and high success rates, UAE has become a preferred treatment option for women with symptomatic fibroids who want to avoid surgery or maintain their fertility.
Compared to traditional surgeries, UAE offers a number of benefits that make it an attractive option for many women. UAE has been shown to be highly effective in treating fibroids, and long-term follow-up studies have found that the majority of women continue to experience symptom relief for up to 10 years after the procedure. If you want to learn more about this, do consult the Vascular department and Dr. ABCD to get specialized treatment.